Abstract C018: Targeting KRAS inhibitor resistance by ferroptosis induction in PDAC
Aparna Padhye(Dana-Farber Cancer Institute), Joseph D. Mancias(Brigham and Women's Hospital), Julien Dilly(Massachusetts Institute of Technology), Qijia Yu(Dana-Farber Cancer Institute), Andrew J. Aguirre(Broad Institute), Hanrong Feng(Dana-Farber Cancer Institute), Nicole Sindoni(Dana-Farber Cancer Institute), Huan Zhang(Harvard University)
Cited by 0
Related Papers
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
|Nature|2017|2k
Activated Kras and <i>Ink4a/Arf</i> deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma
|Genes & Development|2003|1k
Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting
|Cancer Discovery|2016|632